Cervical Dystonia and Chronic Migraine Comorbidity: Background, Diagnosis, and Treatment
OnabotulinumtoxinA in Cervical Dystonia
Botulinum Toxins: Dosing and Duration of Treatment
OnabotulinumtoxinA: Manufacturing, Non-interchangeability, and Non-Medical Switching
Please see Important Safety Information within the video.
Please see full Prescribing Information including Boxed Warning and Medication Guide here.
H. A. (Buz) Jinnah, MD, PhD
American Board of Psychiatry and Neurology
Movement Disorders Neurology
Emory University School of Medicine
Professor of Neurology, Human Genetics, and Pediatrics
Atlanta, GA
Examine the impact of dose on duration of effect when using botulinum toxins for the treatment of cervical dystonia.
This site is intended for U.S. Healthcare Professionals only. Use of and access to this site are subject to the Terms of Use and Privacy Policy.
The information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider.
All decisions regarding patient care must be made by a healthcare provider considering the unique characteristics of the patient.
Copyright © 2024 AbbVie Inc. North Chicago, Illinois, U.S.A. BONT-US-00017-MC. V2, May 2024.